A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.

Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells ...

KRAS is the most frequently mutated oncogene across all human cancers. Although different KRAS mutations have long been thought to exert the same cancer-driving effects, a new study led by UT ...

Neutrophils are everywhere in the bloodstream and are built for speed, rushing to sites of injury or infection to contain ...

A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a ...

Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a breakthrough that could pave the way for targeted type 1 diabetes treatments without ...

Two research articles published in Nature Genetics shed new light on the cellular complexity of glioblastoma, the most aggressive type of brain cancer. An international team of scientists, including ...

Scientists have uncovered a surprising way tumors turn the immune system to their advantage. Researchers at the University of ...